Assessment Of Patients With Borrelia Infection
疏螺旋体感染患者的评估
基本信息
- 批准号:10692041
- 负责人:
- 金额:$ 69.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Tickborne diseases are a serious health threat that has steadily risen, with reported cases more than doubling over the past 13 years. Lyme disease, or Lyme borreliosis, accounts for more than 80% of the reported cases of tickborne diseases in the US. It is estimated that over 476,000 cases of Lyme disease diagnosed and treated per year in the US, and over 200,000 cases estimated in Europe. Our current work addresses the following areas in Lyme disease: development of new tests and biomarkers for infection, investigation of persistence of infection with B. burgdorferi in humans, and investigation of the role of immune response in Lyme disease and post treatment Lyme disease syndrome (PTLDS). We have three clinical protocols exploring diverse aspects of Lyme disease and tickborne infections that are currently open to recruitment. In these, and past clinical studies, we have evaluated more than 800 patients. Together with this large clinical database, we have assembled a large biorepository that has served to explore multiple avenues of research in Lyme borreliosis and tickborne diseases.
In the past year, have a series of publications. We described the characteristics of patients with early Lyme neuroborreliosis presenting with facial palsy in our cohort, pointing attention to important clues in the history (exposure to ticks in an endemic area, but not necessarily a history of recognized tick bite, constitutional symptoms and/or skin lesions, and presentation in the summer months) that help with early diagnosis. Most patients had an excellent recovery, and the recovery was similar for patients who received antibiotics alone or both antibiotics and corticosteroids. In another publication, we showed that B. burgdorferi, which can accumulate intact phospholipids from its environment to support growth, and that antibody responses to host phospholipids occur in mice and patients with acute Lyme disease. Further study will be required to determine whether these antibodies have utility in early diagnosis of Lyme disease, tracking of the response to therapy. We have also help study the serologic response to Anaplasma phagocytophilum and Babesia microti, two emerging tick-borne pathogens in the United States. Using a peptide array to select sets of linear peptides, we identified peptides that can be a useful tool for detection of antibody reactivity to both of these pathogens.
We have also helped with a longitudinal cohort study to characterize the clinical sequelae and persistent symptoms after COVID-19. The initial findings of this study have been published.
Tickborne疾病是一种严重的健康威胁,稳步上升,据报道,在过去的13年中,案件增加了一倍以上。莱姆病(莱姆病)或莱姆毛毛病(Lyme Borreliosis)占美国报道的tick骨疾病病例的80%以上。据估计,在美国,每年诊断和治疗的莱姆病超过476,000例,在欧洲估计超过200,000例病例。我们目前的工作涉及莱姆病的以下领域:开发新的测试和生物标志物,用于感染的新测试和生物标志物,调查人类中伯格多菲利的感染持续性,以及对莱姆病在莱姆病中的作用和治疗后莱姆病疾病综合征(PTLD)的作用。我们有三个临床方案,探讨了目前曾易招募的莱姆病和tick虫感染的各个方面。在这些和过去的临床研究中,我们评估了800多名患者。与这个大型临床数据库一起,我们组装了一个大型的生物库,该生物座探索了莱姆毛促性疾病和tick虫疾病的多种研究途径。
在过去的一年中,有一系列出版物。我们描述了莱姆神经性早期神经性病的患者的特征,在我们的队列中表现出面部麻痹,将注意力集中在历史上的重要线索(暴露于地方性区域的壁虱中,但不一定是公认的tick虫咬伤,宪法症状和/或皮肤病变的病史,以及在夏季诊断的疾病)。大多数患者的恢复良好,单独接受抗生素或抗生素和皮质类固醇的患者的恢复相似。在另一份出版物中,我们表明,B. burgdorferi可以从其环境中积累完整的磷脂以支持生长,并且对宿主磷脂的抗体反应发生在小鼠和急性莱姆病的患者中。将需要进一步的研究来确定这些抗体在早期诊断莱姆病的早期诊断中是否具有效用,并跟踪对治疗的反应。我们还帮助研究了对美国两种新兴的tick传播病原体的吞噬细胞吞噬和贝贝西亚微动物的血清学反应。使用肽阵列选择一组线性肽,我们确定了可以检测对这两种病原体抗体反应性的有用工具的肽。
我们还帮助进行了一项纵向队列研究,以表征Covid-19之后的临床后遗症和持续性症状。这项研究的最初发现已发表。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
ADRIANA R MARQUES的其他基金
Assessment Of Patients With Lyme Infection
莱姆病感染患者的评估
- 批准号:69860026986002
- 财政年份:
- 资助金额:$ 69.43万$ 69.43万
- 项目类别:
Assessment Of Patients With Lyme Infection
莱姆病感染患者的评估
- 批准号:71941037194103
- 财政年份:
- 资助金额:$ 69.43万$ 69.43万
- 项目类别:
Trial Of Varicella Vaccine For The Prevention Of Herpes Zoster
水痘疫苗预防带状疱疹的试验
- 批准号:75922467592246
- 财政年份:
- 资助金额:$ 69.43万$ 69.43万
- 项目类别:
Trial Of Varicella Vaccine For The Prevention Of Herpes
水痘疫苗预防疱疹的试验
- 批准号:73038407303840
- 财政年份:
- 资助金额:$ 69.43万$ 69.43万
- 项目类别:
Assessment Of Patients With Lyme Infection
莱姆病感染患者的评估
- 批准号:66695706669570
- 财政年份:
- 资助金额:$ 69.43万$ 69.43万
- 项目类别:
Trial Of Varicella Vaccine For The Prevention Of Herpes Zoster
水痘疫苗预防带状疱疹的试验
- 批准号:77325497732549
- 财政年份:
- 资助金额:$ 69.43万$ 69.43万
- 项目类别:
Assessment Of Patients With Borrelia Infection
疏螺旋体感染患者的评估
- 批准号:1092775110927751
- 财政年份:
- 资助金额:$ 69.43万$ 69.43万
- 项目类别:
Investigating the Human Immune Response to Ixodes scapularis Tick Bites
研究人体对肩胛硬蜱叮咬的免疫反应
- 批准号:1092797210927972
- 财政年份:
- 资助金额:$ 69.43万$ 69.43万
- 项目类别:
Trial Of Varicella Vaccine For The Prevention Of Herpes Zoster
水痘疫苗预防带状疱疹的试验
- 批准号:81569208156920
- 财政年份:
- 资助金额:$ 69.43万$ 69.43万
- 项目类别:
Novel Therapies for Herpes Simplex Virus Infections
单纯疱疹病毒感染的新疗法
- 批准号:60991476099147
- 财政年份:
- 资助金额:$ 69.43万$ 69.43万
- 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma.
一种针对难治性哮喘中性粒细胞性气道炎症和气道高反应性的新方法。
- 批准号:1065965810659658
- 财政年份:2023
- 资助金额:$ 69.43万$ 69.43万
- 项目类别:
An Inhaled Microbiome-Targeted Biotherapeutic for Treatment of COPD
一种吸入性微生物组靶向生物治疗药物,用于治疗慢性阻塞性肺病
- 批准号:1060088710600887
- 财政年份:2023
- 资助金额:$ 69.43万$ 69.43万
- 项目类别:
Dose escalation clinical trial of high-dose oral montelukast to inform future RCT in children with acute asthma exacerbations
大剂量口服孟鲁司特的剂量递增临床试验为哮喘急性发作儿童的未来随机对照试验提供信息
- 批准号:1064901210649012
- 财政年份:2023
- 资助金额:$ 69.43万$ 69.43万
- 项目类别:
A Mixed Methods Evaluation of Developing COPD Exacerbations in the MARC Cohort
MARC 队列中 COPD 加重的混合方法评估
- 批准号:1060538510605385
- 财政年份:2023
- 资助金额:$ 69.43万$ 69.43万
- 项目类别:
Development of Patient-Tailored Adaptive Treatment Strategies for Acute Severe Ulcerative Colitis
制定针对急性重症溃疡性结肠炎的患者定制适应性治疗策略
- 批准号:1056939710569397
- 财政年份:2023
- 资助金额:$ 69.43万$ 69.43万
- 项目类别: